Paper42889337PubMed
Microbiome-Endocannabinoidome Crosstalk as an Immunometabolic Rheostat in Inflammatory Disease.
Maghembe RS and 3 others. FASEB Bioadv, 2026.
Cite this record
ConductScience Library. Microbiome-Endocannabinoidome Crosstalk as an Immunometabolic Rheostat in Inflammatory Disease. Papers, record 42889337. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/42889337
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Microbiome-Endocannabinoidome Crosstalk as an Immunometabolic Rheostat in Inflammatory Disease.
- Journal
- FASEB Bioadv
- Year
- 2026
- Publication types
- Journal Article, Review
- Revised in PubMed
- 2026-10-19
Source PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References90
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 18305141 | Changes in gut microbiota control metabolic endotoxemia-induced inflammation in high-fat diet-induced obesity and diabetes in mice. | Diabetes | 2008 | https://conductscience.org/library/papers/18305141 | PubMed |
| 2 | 35634468 | The Microbiome and Gut Endocannabinoid System in the Regulation of Stress Responses and Metabolism. | Front Cell Neurosci | 2022 | https://conductscience.org/library/papers/35634468 | PubMed |
| 3 | 27315476 | Modeling Development and Disease with Organoids. | Cell | 2016 | https://conductscience.org/library/papers/27315476 | PubMed |
| 4 | 38790705 | Therapeutic Potential of Palmitoylethanolamide in Gastrointestinal Disorders. | Antioxidants (Basel) | 2024 | https://conductscience.org/library/papers/38790705 | PubMed |
| 5 | 28596366 | Activity-based protein profiling reveals off-target proteins of the FAAH inhibitor BIA 10-2474. | Science | 2017 | https://conductscience.org/library/papers/28596366 | PubMed |
| 6 | 32457482 | Host-microbiota interactions in immune-mediated diseases. | Nat Rev Microbiol | 2020 | https://conductscience.org/library/papers/32457482 | PubMed |
| 7 | 28476144 | Multi-omics approaches to disease. | Genome Biol | 2017 | https://conductscience.org/library/papers/28476144 | PubMed |
| 8 | 37431863 | Gut microbiota-related bile acid metabolism-FXR/TGR5 axis impacts the response to anti-α4β7-integrin therapy in humanized mice with colitis. | Gut Microbes | 2023 | https://conductscience.org/library/papers/37431863 | PubMed |
| 9 | 40283915 | Targeting the Endocannabinoidome: A Novel Approach to Managing Extraintestinal Complications in Inflammatory Bowel Disease. | Pharmaceuticals (Basel) | 2025 | https://conductscience.org/library/papers/40283915 | PubMed |
| 10 | 21471961 | The endogenous cannabinoid system in the gut of patients with inflammatory bowel disease. | Mucosal Immunol | 2011 | https://conductscience.org/library/papers/21471961 | PubMed |
| 11 | 34069940 | Palmitoylethanolamide: A Natural Compound for Health Management. | Int J Mol Sci | 2021 | https://conductscience.org/library/papers/34069940 | PubMed |
| 12 | 27413788 | Endocannabinoids in the Gut. | Cannabis Cannabinoid Res | 2016 | https://conductscience.org/library/papers/27413788 | PubMed |
| 13 | 32433595 | Interaction between microbiota and immunity in health and disease. | Cell Res | 2020 | https://conductscience.org/library/papers/32433595 | PubMed |
| 14 | 21862983 | The microbiome and rheumatoid arthritis. | Nat Rev Rheumatol | 2011 | https://conductscience.org/library/papers/21862983 | PubMed |
| 15 | 33494185 | GPR119 and GPR55 as Receptors for Fatty Acid Ethanolamides, Oleoylethanolamide and Palmitoylethanolamide. | Int J Mol Sci | 2021 | https://conductscience.org/library/papers/33494185 | PubMed |
| 16 | 36778747 | The Gut Microbiome-Endocannabinoidome Axis: A New Way of Controlling Metabolism, Inflammation, and Behavior. | Function (Oxf) | 2023 | https://conductscience.org/library/papers/36778747 | PubMed |
| 17 | 37735572 | Dietary food patterns as determinants of the gut microbiome-endocannabinoidome axis in humans. | Sci Rep | 2023 | https://conductscience.org/library/papers/37735572 | PubMed |
| 18 | 28530168 | Microbe Profile: Akkermansia muciniphila: a conserved intestinal symbiont that acts as the gatekeeper of our mucosa. | Microbiology (Reading) | 2017 | https://conductscience.org/library/papers/28530168 | PubMed |
| 19 | 36977462 | Short chain fatty acids: key regulators of the local and systemic immune response in inflammatory diseases and infections. | Open Biol | 2023 | https://conductscience.org/library/papers/36977462 | PubMed |
| 20 | 27646959 | Tolerogenic dendritic cells. | Semin Immunopathol | 2017 | https://conductscience.org/library/papers/27646959 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Cited by
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/42889337
GET https://conductscience.org/api/papers/v1/42889337/references?page=2